The SURPASS and SURMOUNT trials have led the ADA to consider tirzepatide, along with semaglutide, to be very highly efficacious for weight loss [38]
The subsequent rise in circulating GH stimulates hepatic production of IGF-1 , which mediates downstream anabolic and lipolytic effects via the PI3K-Akt-mTOR and JAK-STAT pathways
Revised: 1/2026 Full Prescribing Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Patients may be trying to lower blood pressure, reduce diabetes risk, improve mobility, prepare for a procedure, sleep better, reduce joint pain, or feel more confident in daily life
Legality The use of BPC-157, either for sport or for medical treatment, is not legal in most countries
Common questions and quick answers How long until I notice changes